Showing results (11-20 of 77) with videos related to
Sort By:
Pageof 8
The Journal of Infection|May 23, 2022
Patients with transplantation have reduced mortality in bacteraemia: Analysis of data from a randomised trialFergus Hamilton, Rebecca Evans, Peter Ghazal, et al.The Journal of Antimicrobial Chemotherapy|October 31, 2003
Comparison of BSAC agar dilution and NCCLS broth microdilution MIC methods for in vitro susceptibility testing of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis: the BSAC Respiratory Resistance Surveillance ProgrammeRosy Reynolds, Jemma Shackcloth, David Felmingham, et al.The Journal of Antimicrobial Chemotherapy|October 31, 2003
Antimicrobial susceptibility of lower respiratory tract pathogens in Great Britain and Ireland 1999-2001 related to demographic and geographical factors: the BSAC Respiratory Resistance Surveillance ProgrammeRosy Reynolds, Jemma Shackcloth, David Felmingham, et al.Antimicrobial Agents and Chemotherapy|March 7, 2012
Bactericidal activity of multiple combinations of tigecycline and colistin against NDM-1-producing EnterobacteriaceaeMahableshwar Albur, Alan Noel, Karen Bowker, et al.International Journal of Antimicrobial Agents|April 25, 2020
The pharmacodynamics of fosfomycin against Staphylococcus aureus studied in an in vitro model of infectionAlan Noel, Marie Attwood, Karen Bowker, et al.Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|April 24, 2018
Retrospective review of serum teicoplanin concentrations in clinical trials and their relationship to clinical outcomeAlasdair MacGowan, Les White, David Reeves, et al.The Journal of Antimicrobial Chemotherapy|December 20, 2024
Trends in fluoroquinolone prescribing in UK primary and secondary care between 2019 and 2023Fergus Hamilton, Elizabeth Darley, Karon Arnold, et al.International Journal of Antimicrobial Agents|September 21, 2015
The combination of colistin and fosfomycin is synergistic against NDM-1-producing Enterobacteriaceae in in vitro pharmacokinetic/pharmacodynamic model experimentsMahableshwar S Albur, Alan Noel, Karen Bowker, et al.The Journal of Antimicrobial Chemotherapy|August 1, 2023
Antibacterial effect of seven days exposure to ceftolozane-tazobactam as monotherapy and in combination with fosfomycin or tobramycin against Pseudomonas aeruginosa with ceftolozane-tazobactam MICs at or above 4 mg/l in an in vitro pharmacokinetic modelMarie Attwood, Pippa Griffin, Alan R Noel, et al.Antimicrobial Agents and Chemotherapy|December 30, 2015
Suppression of Emergence of Resistance in Pathogenic Bacteria: Keeping Our Powder Dry, Part 2G L Drusano, William Hope, Alasdair MacGowan, et al.Pageof 8